164 related articles for article (PubMed ID: 12107996)
1. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
3. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
[TBL] [Abstract][Full Text] [Related]
4. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
[TBL] [Abstract][Full Text] [Related]
5. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
[TBL] [Abstract][Full Text] [Related]
7. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Ammassari A; Grisetti S; Paglia MG; Gentile M; Cingolani A; Murri R; Liuzzi G; Monforte AD; Antinori A
J Infect Dis; 2000 Oct; 182(4):1077-83. PubMed ID: 10979902
[TBL] [Abstract][Full Text] [Related]
8. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.
Berenguer J; Miralles P; Arrizabalaga J; Ribera E; Dronda F; Baraia-Etxaburu J; Domingo P; Márquez M; Rodriguez-Arrondo FJ; Laguna F; Rubio R; Lacruz Rodrigo J; Mallolas J; de Miguel V;
Clin Infect Dis; 2003 Apr; 36(8):1047-52. PubMed ID: 12684918
[TBL] [Abstract][Full Text] [Related]
9. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
[TBL] [Abstract][Full Text] [Related]
10. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y
J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
[TBL] [Abstract][Full Text] [Related]
15. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment.
Gray F; Bazille C; Adle-Biassette H; Mikol J; Moulignier A; Scaravilli F
J Neurovirol; 2005; 11 Suppl 3():16-22. PubMed ID: 16540449
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
19. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.
Marzocchetti A; Cingolani A; Giambenedetto SD; Ammassari A; Giancola ML; Cauda R; Antinori A; Luca AD
J Neurovirol; 2005 Apr; 11(2):219-24. PubMed ID: 16036800
[TBL] [Abstract][Full Text] [Related]
20. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies.
García-Suárez J; de Miguel D; Krsnik I; Bañas H; Arribas I; Burgaleta C
Am J Hematol; 2005 Dec; 80(4):271-81. PubMed ID: 16315252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]